<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03091075</url>
  </required_header>
  <id_info>
    <org_study_id>HS-17-00272</org_study_id>
    <nct_id>NCT03091075</nct_id>
  </id_info>
  <brief_title>Oxandrolone Rotator Cuff Trial</brief_title>
  <acronym>ORCT</acronym>
  <official_title>Ability of Oral Steroid (Oxandrolone) to Halt Fatty Infiltration and Aid Rotator Cuff Healing: A Double-Blind, Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Southern California</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Southern California</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is about healing after a rotator cuff tear repair procedure. We hope to learn if a
      biologic medication: Oxandrolone, a synthetic derivative of the human hormone Testosterone
      (the principal male sex hormone and an anabolic steroid), given for 12 weeks following
      rotator cuff repair, is effective in aiding in the healing process and restoring muscle mass.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rotator cuff tears are currently one of the most common causes of musculoskeletal pain and
      disability; the biologic sequelae of a chronic tear are muscle atrophy, fatty infiltration,
      and intercellular fibrosis of the torn muscle-tendon unit. Recently, researchers have
      attempted to address the biologic sequelae of chronic rotator cuff tearing with animal
      studies examining the effects of anabolic steroids on rotator cuff healing, demonstrating
      that when administered as an adjuvant to rotator cuff repair, anabolic steroids can halt
      fatty infiltration, decrease muscle atrophy, and promote healing. The purpose of this study
      will be to conduct the first clinical trial using an oral anabolic agent (Oxandrolone, an
      oral synthetic derivative of testosterone that has been shown to aid in beneficial tissue
      healing in burn patients) to promote rotator cuff healing. Men and women aged 40 - 75
      scheduled for rotator cuff repair, who have failed nonoperative management of chronic, full
      thickness rotator cuff tears confirmed by MRI, will be randomized into one of two groups, a
      control group (receiving placebo medication) and an experimental group (receiving oral
      Oxandrolone), with dosing (males 12 mg BID, female 6 mg BID) beginning at time of surgery and
      continuing for 12 weeks postoperative. Allocation will be performed using computer software
      and will occur at the pharmacy to ensure that all investigators are blinded. All participants
      will undergo a standardized rehabilitation protocol for rotator cuff repair, supervised by a
      licensed physical therapist.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2018</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Men and women aged 40 - 75 scheduled for rotator cuff repair, who have failed nonoperative management of chronic, full thickness rotator cuff tears confirmed by MRI, will be randomized into one of two groups, a control group (receiving placebo medication) and an experimental group receiving oral Oxandrolone (males 12 mg BID (24 mg per day) and females 6 mg BID (12 mg per day)), with dosing beginning at time of surgery and continuing for 12 weeks postoperative.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Allocation will be performed using computer software and will occur at the pharmacy to ensure that all investigators are blinded.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>change in structural integrity of the rotator cuff/tendon healing</measure>
    <time_frame>baseline, 12 weeks, 52 weeks and 104 weeks postoperative</time_frame>
    <description>assessed by MRI, classified based on the Sugaya classification and Goutallier Grade</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in ASES shoulder score</measure>
    <time_frame>baseline; procedure day; 2 weeks, 6 weeks, 12 weeks, 24 weeks, 52 weeks, 104 weeks</time_frame>
    <description>American Shoulder Elbow Surgeon's Shoulder Score, Patient Questionnaire</description>
  </secondary_outcome>
  <other_outcome>
    <measure>change in VAS pain scale</measure>
    <time_frame>baseline; procedure day; 2 weeks, 6 weeks, 12 weeks, 24 weeks, 52 weeks, 104 weeks</time_frame>
    <description>Visual Analog Score - pain scale, patient questionnaire</description>
  </other_outcome>
  <other_outcome>
    <measure>change in PASS Score</measure>
    <time_frame>baseline; procedure day; 2 weeks, 6 weeks, 12 weeks, 24 weeks, 52 weeks, 104 weeks</time_frame>
    <description>Patient Acceptabe Symptom State, patient questionnaire</description>
  </other_outcome>
  <other_outcome>
    <measure>change in Functional Outcome - Shoulder Strength</measure>
    <time_frame>baseline; procedure day; 2 weeks, 6 weeks, 12 weeks, 24 weeks, 52 weeks, 104 weeks</time_frame>
    <description>isometric shoulder strength measures using a handheld dynamometer</description>
  </other_outcome>
  <other_outcome>
    <measure>change in Body Composition</measure>
    <time_frame>baseline; procedure day; 2 weeks, 6 weeks, 12 weeks, 24 weeks, 52 weeks, 104 weeks</time_frame>
    <description>body composition testing by bioelectric impedence</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Rotator Cuff Tear</condition>
  <arm_group>
    <arm_group_label>Treatment Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>receiving oral Oxandrolone 24 mg (12mg tablets) per day if male and 12 mg Oxandrolone per day if female, with dosing starting at time of surgery and continuing 12 weeks postoperative</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>receiving placebo medication (Placebo Oral Tablet), oral tablet, with dosing beginning at time of surgery and continuing for 12 weeks postoperative</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxandrolone Pill</intervention_name>
    <description>Treatment group will receive 24 mg Oxandrolone per day if male and 12 mg Oxandrolone per day if female, with dosing starting at time of surgery and continuing 12 weeks postoperative</description>
    <arm_group_label>Treatment Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Oral Tablet</intervention_name>
    <description>Placebo group will receive a placebo oral tablet, beginning at the time of surgery and continuing 12 weeks postoperative</description>
    <arm_group_label>Placebo Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  scheduled for rotator cuff repair

          -  failed nonoperative management of chronic, full thickness rotator cuff tears

          -  full thickness rotator cuff tear confirmed on MRI

        Exclusion Criteria:

          -  patients with prior shoulder surgery or prior rotator cuff repair

          -  tears larger than 5 cm

          -  significant glenohumeral arthritis (Hamada Grade 2 or higher)

          -  Untreated diabetes mellitus

          -  Pituitary tumor

          -  Rheumatoid arthritis

          -  Uncontrolled hypertension

          -  Congestive heart failure

          -  Myocardial infarction within the past 6 months

          -  End-stage renal disease

          -  DVT within the past 6 months

          -  Disorder of the coagulation system

          -  Currently taking anticoagulation

          -  Claustrophobia

          -  Prior or current use of anabolic steroids

          -  Chromosomal disorders

          -  Prostate cancer

          -  Breast cancer

          -  Hypercalcemia

          -  Medications that interfere with testosterone production or function, including but not
             limited to 5 alpha-reductase inhibitors

          -  Any other condition or treatment interfering with completion of the trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>George R Hatch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Southern California</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>George R Hatch, MD</last_name>
    <phone>323-442-5860</phone>
    <email>ghatch@med.usc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Keemia Soraya Heidari, BA</last_name>
    <phone>323-442-5860</phone>
    <email>kheidari@usc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Keck School of Medicine of the University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Keemia Soraya Heidari, BA</last_name>
      <phone>323-442-5680</phone>
      <email>kheidari@usc.edu</email>
    </contact>
    <investigator>
      <last_name>George R Hatch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Keemia Soraya Heidari, BA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anthony Essilfie, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Seth Gamradt, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alan Gurler, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lori Michener, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Reza Omid, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Todd Schroeder, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Tibone, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>C. Thomas Vangsness, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexander Weber, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Wolf SE, Thomas SJ, Dasu MR, Ferrando AA, Chinkes DL, Wolfe RR, Herndon DN. Improved net protein balance, lean mass, and gene expression changes with oxandrolone treatment in the severely burned. Ann Surg. 2003 Jun;237(6):801-10; discussion 810-1.</citation>
    <PMID>12796576</PMID>
  </reference>
  <reference>
    <citation>Jeschke MG, Finnerty CC, Suman OE, Kulp G, Mlcak RP, Herndon DN. The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn. Ann Surg. 2007 Sep;246(3):351-60; discussion 360-2.</citation>
    <PMID>17717439</PMID>
  </reference>
  <reference>
    <citation>Schroeder ET, Vallejo AF, Zheng L, Stewart Y, Flores C, Nakao S, Martinez C, Sattler FR. Six-week improvements in muscle mass and strength during androgen therapy in older men. J Gerontol A Biol Sci Med Sci. 2005 Dec;60(12):1586-92.</citation>
    <PMID>16424293</PMID>
  </reference>
  <reference>
    <citation>Gerber C, Fuchs B, Hodler J. The results of repair of massive tears of the rotator cuff. J Bone Joint Surg Am. 2000 Apr;82(4):505-15.</citation>
    <PMID>10761941</PMID>
  </reference>
  <reference>
    <citation>Meyer DC, Wieser K, Farshad M, Gerber C. Retraction of supraspinatus muscle and tendon as predictors of success of rotator cuff repair. Am J Sports Med. 2012 Oct;40(10):2242-7. Epub 2012 Aug 27.</citation>
    <PMID>22926748</PMID>
  </reference>
  <reference>
    <citation>Sugaya H, Maeda K, Matsuki K, Moriishi J. Repair integrity and functional outcome after arthroscopic double-row rotator cuff repair. A prospective outcome study. J Bone Joint Surg Am. 2007 May;89(5):953-60.</citation>
    <PMID>17473131</PMID>
  </reference>
  <reference>
    <citation>Goutallier D, Postel JM, Bernageau J, Lavau L, Voisin MC. Fatty muscle degeneration in cuff ruptures. Pre- and postoperative evaluation by CT scan. Clin Orthop Relat Res. 1994 Jul;(304):78-83.</citation>
    <PMID>8020238</PMID>
  </reference>
  <reference>
    <citation>Le BT, Wu XL, Lam PH, Murrell GA. Factors predicting rotator cuff retears: an analysis of 1000 consecutive rotator cuff repairs. Am J Sports Med. 2014 May;42(5):1134-42. doi: 10.1177/0363546514525336. Epub 2014 Apr 18.</citation>
    <PMID>24748610</PMID>
  </reference>
  <reference>
    <citation>Kim HM, Caldwell JM, Buza JA, Fink LA, Ahmad CS, Bigliani LU, Levine WN. Factors affecting satisfaction and shoulder function in patients with a recurrent rotator cuff tear. J Bone Joint Surg Am. 2014 Jan 15;96(2):106-12. doi: 10.2106/JBJS.L.01649.</citation>
    <PMID>24430409</PMID>
  </reference>
  <reference>
    <citation>Kelly BT, Kadrmas WR, Speer KP. The manual muscle examination for rotator cuff strength. An electromyographic investigation. Am J Sports Med. 1996 Sep-Oct;24(5):581-8.</citation>
    <PMID>8883676</PMID>
  </reference>
  <reference>
    <citation>Makhni EC, Steinhaus ME, Morrow ZS, Jobin CM, Verma NN, Cole BJ, Bach BR Jr. Outcomes assessment in rotator cuff pathology: what are we measuring? J Shoulder Elbow Surg. 2015 Dec;24(12):2008-15. doi: 10.1016/j.jse.2015.08.007. Epub 2015 Oct 21. Review.</citation>
    <PMID>26475640</PMID>
  </reference>
  <reference>
    <citation>Richards RR, An KN, Bigliani LU, Friedman RJ, Gartsman GM, Gristina AG, Iannotti JP, Mow VC, Sidles JA, Zuckerman JD. A standardized method for the assessment of shoulder function. J Shoulder Elbow Surg. 1994 Nov;3(6):347-52. doi: 10.1016/S1058-2746(09)80019-0. Epub 2009 Feb 13.</citation>
    <PMID>22958838</PMID>
  </reference>
  <reference>
    <citation>Michener LA, Snyder AR, Leggin BG. Responsiveness of the numeric pain rating scale in patients with shoulder pain and the effect of surgical status. J Sport Rehabil. 2011 Feb;20(1):115-28.</citation>
    <PMID>21411827</PMID>
  </reference>
  <reference>
    <citation>Michener LA. Patient- and clinician-rated outcome measures for clinical decision making in rehabilitation. J Sport Rehabil. 2011 Feb;20(1):37-45. Review.</citation>
    <PMID>21411821</PMID>
  </reference>
  <reference>
    <citation>Mintken PE, McDevitt AW, Cleland JA, Boyles RE, Beardslee AR, Burns SA, Haberl MD, Hinrichs LA, Michener LA. Cervicothoracic Manual Therapy Plus Exercise Therapy Versus Exercise Therapy Alone in the Management of Individuals With Shoulder Pain: A Multicenter Randomized Controlled Trial. J Orthop Sports Phys Ther. 2016 Aug;46(8):617-28. doi: 10.2519/jospt.2016.6319.</citation>
    <PMID>27477473</PMID>
  </reference>
  <reference>
    <citation>Yamaguchi K, Ditsios K, Middleton WD, Hildebolt CF, Galatz LM, Teefey SA. The demographic and morphological features of rotator cuff disease. A comparison of asymptomatic and symptomatic shoulders. J Bone Joint Surg Am. 2006 Aug;88(8):1699-704.</citation>
    <PMID>16882890</PMID>
  </reference>
  <reference>
    <citation>Vitale MA, Vitale MG, Zivin JG, Braman JP, Bigliani LU, Flatow EL. Rotator cuff repair: an analysis of utility scores and cost-effectiveness. J Shoulder Elbow Surg. 2007 Mar-Apr;16(2):181-7.</citation>
    <PMID>17399623</PMID>
  </reference>
  <reference>
    <citation>Ensor KL, Kwon YW, Dibeneditto MR, Zuckerman JD, Rokito AS. The rising incidence of rotator cuff repairs. J Shoulder Elbow Surg. 2013 Dec;22(12):1628-32. doi: 10.1016/j.jse.2013.01.006. Epub 2013 Mar 1.</citation>
    <PMID>23466172</PMID>
  </reference>
  <reference>
    <citation>Colvin AC, Egorova N, Harrison AK, Moskowitz A, Flatow EL. National trends in rotator cuff repair. J Bone Joint Surg Am. 2012 Feb 1;94(3):227-33. doi: 10.2106/JBJS.J.00739.</citation>
    <PMID>22298054</PMID>
  </reference>
  <reference>
    <citation>Lee TQ. Current biomechanical concepts for rotator cuff repair. Clin Orthop Surg. 2013 Jun;5(2):89-97. doi: 10.4055/cios.2013.5.2.89. Epub 2013 May 15.</citation>
    <PMID>23730471</PMID>
  </reference>
  <reference>
    <citation>Boileau P, Brassart N, Watkinson DJ, Carles M, Hatzidakis AM, Krishnan SG. Arthroscopic repair of full-thickness tears of the supraspinatus: does the tendon really heal? J Bone Joint Surg Am. 2005 Jun;87(6):1229-40.</citation>
    <PMID>15930531</PMID>
  </reference>
  <reference>
    <citation>Galatz LM, Ball CM, Teefey SA, Middleton WD, Yamaguchi K. The outcome and repair integrity of completely arthroscopically repaired large and massive rotator cuff tears. J Bone Joint Surg Am. 2004 Feb;86-A(2):219-24.</citation>
    <PMID>14960664</PMID>
  </reference>
  <reference>
    <citation>Björnsson HC, Norlin R, Johansson K, Adolfsson LE. The influence of age, delay of repair, and tendon involvement in acute rotator cuff tears: structural and clinical outcomes after repair of 42 shoulders. Acta Orthop. 2011 Apr;82(2):187-92. doi: 10.3109/17453674.2011.566144. Epub 2011 Mar 24.</citation>
    <PMID>21434791</PMID>
  </reference>
  <reference>
    <citation>Moraiti C, Valle P, Maqdes A, Boughebri O, Dib C, Giakas G, Kany J, Elkholti K, Garret J, Katz D, Leclère FM, Valenti P. Comparison of functional gains after arthroscopic rotator cuff repair in patients over 70 years of age versus patients under 50 years of age: a prospective multicenter study. Arthroscopy. 2015 Feb;31(2):184-90. doi: 10.1016/j.arthro.2014.08.020. Epub 2014 Nov 11.</citation>
    <PMID>25442647</PMID>
  </reference>
  <reference>
    <citation>Gerber C, Meyer DC, Schneeberger AG, Hoppeler H, von Rechenberg B. Effect of tendon release and delayed repair on the structure of the muscles of the rotator cuff: an experimental study in sheep. J Bone Joint Surg Am. 2004 Sep;86-A(9):1973-82.</citation>
    <PMID>15342760</PMID>
  </reference>
  <reference>
    <citation>Patel S, Gualtieri AP, Lu HH, Levine WN. Advances in biologic augmentation for rotator cuff repair. Ann N Y Acad Sci. 2016 Nov;1383(1):97-114. doi: 10.1111/nyas.13267. Epub 2016 Oct 17. Review.</citation>
    <PMID>27750374</PMID>
  </reference>
  <reference>
    <citation>Ruiz-Moneo P, Molano-Muñoz J, Prieto E, Algorta J. Plasma rich in growth factors in arthroscopic rotator cuff repair: a randomized, double-blind, controlled clinical trial. Arthroscopy. 2013 Jan;29(1):2-9. doi: 10.1016/j.arthro.2012.08.014.</citation>
    <PMID>23276410</PMID>
  </reference>
  <reference>
    <citation>Rodeo SA, Delos D, Williams RJ, Adler RS, Pearle A, Warren RF. The effect of platelet-rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. Am J Sports Med. 2012 Jun;40(6):1234-41. doi: 10.1177/0363546512442924. Epub 2012 Apr 10.</citation>
    <PMID>22495146</PMID>
  </reference>
  <reference>
    <citation>Gulotta LV, Kovacevic D, Ehteshami JR, Dagher E, Packer JD, Rodeo SA. Application of bone marrow-derived mesenchymal stem cells in a rotator cuff repair model. Am J Sports Med. 2009 Nov;37(11):2126-33. doi: 10.1177/0363546509339582. Epub 2009 Aug 14.</citation>
    <PMID>19684297</PMID>
  </reference>
  <reference>
    <citation>Gerber C, Meyer DC, Nuss KM, Farshad M. Anabolic steroids reduce muscle damage caused by rotator cuff tendon release in an experimental study in rabbits. J Bone Joint Surg Am. 2011 Dec 7;93(23):2189-95. doi: 10.2106/JBJS.J.01589.</citation>
    <PMID>22159854</PMID>
  </reference>
  <reference>
    <citation>Gerber C, Meyer DC, Flück M, Benn MC, von Rechenberg B, Wieser K. Anabolic Steroids Reduce Muscle Degeneration Associated With Rotator Cuff Tendon Release in Sheep. Am J Sports Med. 2015 Oct;43(10):2393-400. doi: 10.1177/0363546515596411. Epub 2015 Aug 24.</citation>
    <PMID>26304962</PMID>
  </reference>
  <reference>
    <citation>Hertzog MA. Considerations in determining sample size for pilot studies. Res Nurs Health. 2008 Apr;31(2):180-91. doi: 10.1002/nur.20247. Review.</citation>
    <PMID>18183564</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 13, 2017</study_first_submitted>
  <study_first_submitted_qc>March 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2017</study_first_posted>
  <last_update_submitted>January 12, 2018</last_update_submitted>
  <last_update_submitted_qc>January 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Southern California</investigator_affiliation>
    <investigator_full_name>George F.</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Rotator Cuff Tear</keyword>
  <keyword>Rotator Cuff</keyword>
  <keyword>Anabolic Steroid</keyword>
  <keyword>Testosterone</keyword>
  <keyword>Oxandrolone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rotator Cuff Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxandrolone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be shared as required with the USC Health Sciences Institutional Review Board. Participant data will be coded with coding identifiers kept separately by research personnel only and destroyed upon completion of the study.</ipd_description>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_id>APP-17-01020</doc_id>
      <doc_type>Study Protocol</doc_type>
      <doc_url>http://istar.usc.edu</doc_url>
    </study_doc>
    <study_doc>
      <doc_id>APP-17-01020</doc_id>
      <doc_type>Informed Consent Form</doc_type>
      <doc_url>http://istar.usc.edu</doc_url>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

